Actinomycosis Market Size

Actinomycosis Market size is anticipated to reach USD 20 billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of actinomycosis was over USD 10 billion. The expanding availability of antibiotics and other treatments is one of the main growth drivers driving the market. The need for these treatments is anticipated to increase as more people gain access to them. Consequently, this presents a noteworthy prospect for the companies to broaden their customer base and augment their market share. According to a recent report, global antibiotic consumption is expected to increase by 200% between 2015 and 2030.

Actinomycosis is a rare infectious disease that occurs when bacteria spread from one part of the body to another via body tissues. It can lead to linked abscesses, pain, and inflammation over time. The most common type of Actinomyces infection is orocervicofacial actinomycosis. According to an article published in Antimicrobe, it accounts for 50% of all cases.